Patents by Inventor Cheung-Tak Hung

Cheung-Tak Hung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER
    Publication number: 20230172926
    Abstract: The application pertains to pharmaceutical combinations of orally administered paclitaxel and a P-gp inhibitor. The pharmaceutical combinations are suitable for the treatment of cancer in a subject and for reducing or preventing toxicity, hypersensitivity-type infusion reactions, and other negative outcomes resulting from or associated with intravenously administered paclitaxel (e.g., Taxol® or paclitaxel formulated with Cremophor®) therapy in a subject suffering from cancer.
    Type: Application
    Filed: October 4, 2022
    Publication date: June 8, 2023
    Inventors: Min-Fun Rudolf KWAN, E. Douglas KRAMER, Gerald J. FETTERLY, JR., Cheung-Tak HUNG, Christopher Glyn Charles Alexander JACKSON, Paul William GLUE
  • THERAPEUTIC COMBINATIONS OF ORALLY ADMINISTERED PACLITAXEL AND A P-gp INHIBITOR FOR THE TREATMENT OF CANCER
    Publication number: 20180207148
    Abstract: The application pertains to pharmaceutical combinations of orally administered paclitaxel and a P-gp inhibitor. The pharmaceutical combinations are suitable for the treatment of cancer in a subject and for reducing or preventing toxicity, hypersensitivity-type infusion reactions, and other negative outcomes resulting from or associated with intravenously administered paclitaxel (e.g., Taxol® or paclitaxel formulated with Cremophor®) therapy in a subject suffering from cancer.
    Type: Application
    Filed: July 21, 2016
    Publication date: July 26, 2018
    Inventors: Min-Fun Rudolf KWAN, E. Douglas KRAMER, Gerald J. FETTERLY, Jr., Cheung-Tak HUNG, Christopher Glyn Charles Alexander JACKSON, Paul William GLUE
  • Synthetic skin substitutes
    Patent number: 5196190
    Abstract: Membranes suitable for use as wound dressings and in particular as synthetic skin substitutes are disclosed. The membranes consist of a natural or synthetic polymer, a non-gellable polysaccharide and a cross-linking agent.The membranes of the invention may contain one or more additional components selected from water-loss control agents, emulsifying agents and plasticizers. An internal reinforcing material may also be provided to supplement the inherent mechanical strength of the membrane.Methods of forming such membranes are also disclosed.
    Type: Grant
    Filed: October 3, 1990
    Date of Patent: March 23, 1993
    Assignee: Zenith Technology Corporation, Limited
    Inventors: Avinash Nangia, Cheung-Tak Hung